Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002427089 | SCV002743601 | pathogenic | Hereditary cancer-predisposing syndrome | 2018-02-22 | criteria provided, single submitter | clinical testing | The p.E908* pathogenic mutation (also known as c.2722G>T), located in coding exon 4 of the MSH6 gene, results from a G to T substitution at nucleotide position 2722. This changes the amino acid from a glutamic acid to a stop codon within coding exon 4. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Cancer Genomics Laboratory, |
RCV000845243 | SCV000965671 | affects | Cerebellar medulloblastoma | no assertion criteria provided | case-control |